logo

Crowdly

Browser

Add to Chrome

QInB=43 A patient with myasthenia gravis is treated with pyridostigmine (60 m...

✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.

QInB=43

A patient with myasthenia gravis is treated with pyridostigmine (60 mg orally every six hours). Pyridostigmine has an oral bioavailability of approximately 75% and a half-life ranging from 3–4 hours.

What is the primary mechanism by which pyridostigmine improves muscle strength?

0%
0%
0%
0%
100%
More questions like this

Want instant access to all verified answers on moodle.bgu.ac.il?

Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!

Browser

Add to Chrome